The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives

Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice

(2013) Zongxian Cao et al.   GASTROENTEROLOGY

Bacterial lipopolyshaccaride inhibits CB2 receptor expression in human monocytic cells

(2013) Vedrana Reichenbach et al.   GUT

Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

(2012) Katrin Palumbo-Zerr et al.   ANNALS OF THE RHEUMATIC DISEASES

Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies

(2012) Sabine Steffens et al.   BRITISH JOURNAL OF PHARMACOLOGY

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

(2012) Joseph Tam et al.   Cell Metabolism

Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders

(2012) Cristoforo Silvestri et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Management of bacterial infections in cirrhosis

(2012) Javier Fernández et al.   JOURNAL OF HEPATOLOGY

Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease

(2012) Francesca Rossi et al.   PLoS One

Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity

(2011) Alan Fulp et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

(2011) A Mallat et al.   BRITISH JOURNAL OF PHARMACOLOGY

Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis

(2011) Ferdinando A Giannone et al.   LABORATORY INVESTIGATION

Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance

(2011) Louis J. Aronne et al.   Obesity

Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation

(2010) I Magen et al.   BRITISH JOURNAL OF PHARMACOLOGY

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

(2010) NL Cluny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

(2010) Y Avraham et al.   BRITISH JOURNAL OF PHARMACOLOGY

Recent advances in the understanding of the role of the endocannabinoid system in liver diseases

(2010) Li Huang et al.   DIGESTIVE AND LIVER DISEASE

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

(2010) Fatima Teixeira-Clerc et al.   HEPATOLOGY

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

(2010) Joseph Tam et al.   JOURNAL OF CLINICAL INVESTIGATION

Mechanisms of TNFα-induced cardiac dysfunction in cholestatic bile duct-ligated mice: Interaction between TNFα and endocannabinoids

(2010) Ying-Ying Yang et al.   JOURNAL OF HEPATOLOGY

The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension

(2010) Han-Chieh Lin et al.   JOURNAL OF HEPATOLOGY

The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior

(2010) P.A. Randall et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

(2009) Sumner H. Burstein et al.   AAPS Journal

The role of the endocannabinoid system in liver diseases

(2009) Paolo Caraceni et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

An introduction to the endocannabinoid system: from the early to the latest concepts

(2009) Luciano De Petrocellis et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists

(2009) Helen Butler et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Cannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis

(2009) Marco Domenicali et al.   GASTROENTEROLOGY

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation

(2009) Iddo Magen et al.   JOURNAL OF HEPATOLOGY

Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels

(2009) Luciano De Petrocellis et al.   Journal of Neuroimmune Pharmacology

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis

(2009) Paolo Caraceni et al.   LIVER INTERNATIONAL

The psychiatric side-effects of rimonabant

(2009) Fabrício A. Moreira et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice

(2008) Yosefa Avraham et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

(2008) Fabrizio Montecucco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Endocannabinoids in Liver Disease and Hepatic Encephalopathy

(2008) Iddo Magen et al.   CURRENT PHARMACEUTICAL DESIGN

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

(2008) L. Van Gaal et al.   DIABETES CARE

The management of portal hypertension: Rational basis, available treatments and future options

(2008) Jaime Bosch et al.   JOURNAL OF HEPATOLOGY

Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver

(2007) A. Mallat et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The complications of promiscuity: endocannabinoid action and metabolism

(2007) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY